Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,050 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Half versus normal saline irrigation during catheter ablation of outflow tract ventricular arrhythmias (HALF): a multi-center, parallel, open-label, randomized controlled study.
Dong Y, Wang H, Ma K, Ling Z, Zhao D, Wang Y, Zhang Z, Shao M, Song H, Jiang W, Yang K, Chen Q, Kojodjojo P, Ullah I, Cao K, Chen M, Zhang F; FHRS and HALF study investigators. Dong Y, et al. Among authors: ullah i. J Interv Card Electrophysiol. 2023 Dec;66(9):2143-2151. doi: 10.1007/s10840-023-01558-0. Epub 2023 May 19. J Interv Card Electrophysiol. 2023. PMID: 37204671 Clinical Trial.
Impact of hemodialysis on efficacies of the antiplatelet agents in coronary artery disease patients complicated with end-stage renal disease.
Ye Z, Wang Q, Ullah I, Lin Q, Wu T, Yang M, Fan Y, Dong Z, Wang T, Teng J, Hua R, Tang Y, Li Y, Gong X, Yuan L, Tao Z, Li C. Ye Z, et al. Among authors: ullah i. J Thromb Thrombolysis. 2024 Apr;57(4):558-565. doi: 10.1007/s11239-023-02924-5. Epub 2024 Feb 23. J Thromb Thrombolysis. 2024. PMID: 38393676 Free PMC article.
Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.
Ying L, Wang J, Li J, Teng J, Zhang X, Ullah I, Samee A, Xu K, Chen J, Xu L, Zhu H, Li J, Yang L, Wang F, Fan Y, Zhang J, Lu Y, Gong X, Shi L, Eikelboom JW, Li C. Ying L, et al. Among authors: ullah i. Br J Haematol. 2022 Jan;196(2):424-432. doi: 10.1111/bjh.17847. Epub 2021 Oct 5. Br J Haematol. 2022. PMID: 34611892 Clinical Trial.
Impact of Insulin Receptor Substrate-1 rs956115 and CYP2C19 rs4244285 Genotypes on Clinical Outcome of Patients Undergoing Percutaneous Coronary Intervention.
Zong J, Tang Y, Wang T, Ullah I, Xu K, Wang J, Chen P, Chen Z, Zhu T, Chen J, Li J, Wang F, Yang L, Fan Y, Shi L, Gong X, Eikelboom JW, Zhao Y, Li C. Zong J, et al. Among authors: ullah i. J Am Heart Assoc. 2022 Aug 16;11(16):e025058. doi: 10.1161/JAHA.121.025058. Epub 2022 Aug 5. J Am Heart Assoc. 2022. PMID: 35929455 Free PMC article.
Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study.
Ye Z, Chen P, Tan C, Gong X, Li R, Dong Z, Ullah I, Zhou C, Zhou S, Xie L, Hou X, Han Z, Gu Q, Ma J, Teng J, Tang Y, Zhang Z, Hu H, Zhuang Q, Chen J, Zhu B, Shao F, Li C. Ye Z, et al. Among authors: ullah i. Front Pharmacol. 2022 Sep 8;13:952804. doi: 10.3389/fphar.2022.952804. eCollection 2022. Front Pharmacol. 2022. PMID: 36160382 Free PMC article.
1,050 results